Patents by Inventor Celeste PALLANT

Celeste PALLANT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200123505
    Abstract: The invention relates to retroviral producer cells comprising nucleic acid sequences encoding: gag and pol proteins; envelope protein or a functional substitute thereof; and the RNA genome of the retroviral vector particle, wherein the nucleic acid sequences are all located at a single locus within the retroviral producer cell genome.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 23, 2020
    Inventors: Sabine JOHNSON, Celeste PALLANT, Eirini VAMVA, Conrad VINK
  • Publication number: 20200063144
    Abstract: The invention relates to bacterial artificial chromosomes (BAC) comprising retroviral nucleic acid sequences encoding: gag and pol proteins, and an env protein or a functional substitute thereof, wherein each of the retroviral nucleic acid sequences are arranged as individual expression constructs within the BAC. The invention also relates to uses and methods of transient transfection using said BAC.
    Type: Application
    Filed: October 21, 2019
    Publication date: February 27, 2020
    Inventors: Sabine JOHNSON, Celeste PALLANT, Eirini VAMVA, Conrad VINK
  • Patent number: 10450574
    Abstract: The invention relates to bacterial artificial chromosomes (BAC) comprising retroviral nucleic acid sequences encoding: gag and pol proteins, and an env protein or a functional substitute thereof, wherein each of the retroviral nucleic acid sequences are arranged as individual expression constructs within the BAC. The invention also relates to uses and methods of transient transfection using said BAC.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: October 22, 2019
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Sabine Johnson, Celeste Pallant, Eirini Vamva, Conrad Vink
  • Publication number: 20180320147
    Abstract: The invention relates to retroviral producer cells comprising nucleic acid sequences encoding: gag and pol proteins; envelope protein or a functional substitute thereof; and the RNA genome of the retroviral vector particle, wherein said nucleic acid sequences are all located at a single locus within the retroviral producer cell genome.
    Type: Application
    Filed: July 13, 2018
    Publication date: November 8, 2018
    Inventors: Sabine JOHNSON, Celeste PALLANT, Eirini VAMVA, Conrad VINK
  • Publication number: 20170145427
    Abstract: The invention relates to bacterial artificial chromosomes (BAC) comprising retroviral nucleic acid sequences encoding: gag and pol proteins, and an env protein or a functional substitute thereof, wherein each of the retroviral nucleic acid sequences are arranged as individual expression constructs within the BAC. The invention also relates to uses and methods of transient transfection using said BAC.
    Type: Application
    Filed: November 21, 2016
    Publication date: May 25, 2017
    Inventors: Sabine Johnson, Celeste Pallant, Eirini Vamva, Conrad Vink
  • Publication number: 20170145388
    Abstract: The invention relates to retroviral producer cell comprising nucleic acid sequences encoding: gag and pol proteins; envelope protein or a functional substitute thereof; and the RNA genome of the retroviral vector particle, wherein said nucleic acid sequences are all located at a single locus within the retroviral producer cell genome.
    Type: Application
    Filed: November 21, 2016
    Publication date: May 25, 2017
    Inventors: Sabine JOHNSON, Celeste PALLANT, Eirini VAMVA, Conrad VINK